---
title: "AbbVie (ABBV) Receives a Buy from Scotiabank"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300677093.md"
description: "Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00. Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Amgen. According to TipRanks, Chen has an average return of 6.9% and a 53.61% success rate on recommended stocks. In addition to Scotiabank, AbbVie also received a Buy from RBC Capital’s Trung Huynh in a report issued on September 29. However, on the same day, Citi maintained a Hold rating on AbbVie (NYSE: ABBV)."
datetime: "2026-10-01T11:16:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300677093.md)
  - [en](https://longbridge.com/en/news/300677093.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300677093.md)
generator: "portal-rs"
---

# AbbVie (ABBV) Receives a Buy from Scotiabank

Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00.

Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Merck & Company, and Amgen. According to TipRanks, Chen has an average return of 6.9% and a 53.61% success rate on recommended stocks. 

In addition to Scotiabank, AbbVie also received a Buy from RBC Capital’s Trung Huynh in a report issued on September 29. However, on the same day, Citi maintained a Hold rating on AbbVie (NYSE: ABBV).

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [AbbVie Reveals Positive Data for Eczema and Weight Loss Candidates](https://longbridge.com/en/news/300591646.md)
- [AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo | ABBV Stock News](https://longbridge.com/en/news/300695604.md)
- [AbbVie wins EU approval for paediatric pJIA use](https://longbridge.com/en/news/300559910.md)
- [BUZZ-Genmab at 3-year high after blood cancer drug combination study results](https://longbridge.com/en/news/301001061.md)
- [FDA approves AbbVie’s JUVMO for adults with Parkinson’s disease](https://longbridge.com/en/news/300301299.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**